Steward Partners Investment Advisory’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$368 | – | 4084 |
|
|
2024
Q4 | $368 | Hold |
200
| – | – | ﹤0.01% | 3872 |
|
|
2024
Q3 | $458 | Hold |
200
| – | – | ﹤0.01% | 3606 |
|
|
2024
Q2 | $388 | Hold |
200
| – | – | ﹤0.01% | 3495 |
|
|
2024
Q1 | $576 | Hold |
200
| – | – | ﹤0.01% | 3413 |
|
|
2023
Q4 | $560 | Sell |
200
-300
| -60% | -$840 | ﹤0.01% | 3353 |
|
|
2023
Q3 | $1.27K | Hold |
500
| – | – | ﹤0.01% | 3158 |
|
|
2023
Q2 | $1.54K | Hold |
500
| – | – | ﹤0.01% | 3075 |
|
|
2023
Q1 | $1.43K | Hold |
500
| – | – | ﹤0.01% | 3078 |
|
|
2022
Q4 | $1.87K | Hold |
500
| – | – | ﹤0.01% | 3028 |
|
|
2022
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 3131 |
|
|
2022
Q2 | $1K | Hold |
500
| – | – | ﹤0.01% | 3125 |
|
|
2022
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 3089 |
|
|
2021
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 3019 |
|
|
2021
Q3 | $3K | Sell |
500
-150
| -23% | -$900 | ﹤0.01% | 2925 |
|
|
2021
Q2 | $2K | Hold |
650
| – | – | ﹤0.01% | 6875 |
|
|
2021
Q1 | $2.8K | Sell |
650
-450
| -41% | -$1.94K | ﹤0.01% | 3156 |
|
|
2020
Q4 | $4K | Hold |
1,100
| – | – | ﹤0.01% | 2566 |
|
|
2020
Q3 | $4K | Hold |
1,100
| – | – | ﹤0.01% | 2431 |
|
|
2020
Q2 | $8K | Hold |
1,100
| – | – | ﹤0.01% | 2123 |
|
|
2020
Q1 | $7K | Hold |
1,100
| – | – | ﹤0.01% | 1969 |
|
|
2019
Q4 | $7K | Buy |
+1,100
| New | +$7K | ﹤0.01% | 2145 |
|